Article

Exploring the etiology of Alzheimer disease using molecular genetics

Department of Psychiatry, Washington University School of Medicine, St Louis, MO 63110, USA.
JAMA The Journal of the American Medical Association (Impact Factor: 30.39). 04/1997; 277(10):825-31.
Source: PubMed

ABSTRACT Alzheimer disease (AD), the most common cause of dementia in the elderly, exists in both familial and sporadic forms. Genetic studies have led to the identification of 3 genes, beta-amyloid precursor protein (APP), presenilin-1 (PS1), and presenilin-2 (PS2), which, when mutated, can cause familial forms of AD. Mutations in each of these genes result in elevated levels of A beta42/43, a proteolytic processing fragment of APP that is deposited in brains of AD patients. Transgenic mice carrying AD-causing mutations in APP develop spontaneous age-related beta-amyloid (A beta) deposition and memory impairment. Genetic linkage and association studies have also shown that the epsilon4 allele of the apolipoprotein E (APOE) gene increases risk for AD in a dose-dependent manner in both familial and sporadic forms of AD and may account for as much as 50% of the attributable risk. APOE genotyping may be useful both as an adjunct to diagnosis and in identifying patient groups for therapeutic intervention. While the biological basis for the association of APOE epsilon4 with AD is not known, age of onset and A beta deposition are positively correlated with epsilon4 allele dosage in some cases, suggesting that this risk may also be mediated directly or indirectly through A beta. Because 50% of AD cases have no APOE epsilon4 alleles and families showing mendelian inheritance of AD exist in whom there are no mutations in any of the APP, PS1, or PS2 genes, it is likely that there are additional AD risk factors, both genetic and environmental, still to be identified.

Download full-text

Full-text

Available from: Alison M Goate, Aug 26, 2015
3 Followers
 · 
108 Views
  • Source
    • "Recently, it was shown that the receptor function of megalin could be linked to transcriptional regulation by regulated intramembrane proteolysis (RIP) (Fig. 1) [21] [22]. RIP is an evolutionary conserved process that has been analyzed during investigation of the low density lipoprotein receptor-related protein (LRP) [23], the Notch protein in Drosophila melanogaster [24], and the amyloid precursor protein (APP) [25]. Biemesderfer and co-workers [21] have demonstrated that megalin is processed by protein kinase C and/or ligand binding regulated metalloprotease-mediated ectodomain shedding, and the resulting membrane-associated megalin C-terminal fragment is the substrate of γ-secretase (Fig. 1). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The low-density-lipoprotein receptor megalin (LRP2, gp330) is strongly expressed in the kidney, where it is responsible for the resorption of metabolites from primary urine. One of the main ligands is the complex of retinol and retinol binding protein. Megalin has been hypothesized to be part of the retinol storage system in liver. Considering the role of hepatic stellate cells in retinol storage and fibrogenesis we investigated mouse strains that developed different degrees of fibrosis after challenge with CCl(4). Immunoblotting revealed the invariable expression of the megalin C-terminal fragment independent of liver damage in all strains. However, only a specific cell population in centrilobular areas of fibrotic livers from DBA/2J mice, which were most susceptible for CCl(4)-induced fibrogenesis in our study, was stained using megalin-specific antibodies. Double immunostaining indicated that a subset of hepatic macrophages might represent the megalin-expressing cells in fibrotic liver. Fluorescence activated cell sorting based isolation of hepatic macrophages and megalin specific expression analysis demonstrated the transcription of the whole megalin gene in liver macrophages. We argue that megalin might exhibit a proinflammatory effect by the uptake of retinoids in recruited monocytes, which thereby differentiate to liver macrophages and potentiate fibrogenesis by the release of proinflammatory mediators. Otherwise, megalin might be activated in macrophages during advanced fibrogenesis and act as a negative regulator of proinflammatory genes.
    Biochimica et Biophysica Acta 09/2011; 1812(12):1640-8. DOI:10.1016/j.bbadis.2011.09.003 · 4.66 Impact Factor
  • Source
    • "Such deficits are also the hallmark of many age-related illnesses such as vascular dementia and Alzheimer's disease (AD). AD accounts for 50–70% of cases in older patients and is the cause of more than 100,000 deaths yearly (Albert and Moss, 1988; Evans et al., 1997; Lendon et al., 1997). Mid-range costs for each AD patient are currently estimated at more than $47,500 over the course of the illness, with total cost to the nation estimated at $82.7 billion per year (O'Hara et al., 2001). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Detection of preclinical cognitive deficits is important for identifying those at greatest risk for such disorders as Alzheimer's disease. However, available neuropsychological measures may not be sufficiently sensitive to preclinical cognitive impairment, particularly in high functioning or younger older adults. This study utilizes a battery of computerized cognitive tests (Cognometer) designed to provide a more sensitive measure of age-related cognitive performance by incorporating speed-of-processing components. Fifty-one community-dwelling older adults were administered the Cognometer battery, which incorporates speed-of-processing components into measures of verbal, spatial and working memory, attention, and visuo-spatial ability. Performance of 18 subjects with the epsilon4 allele was compared to that of 33 subjects without the epsilon4 allele. A brief battery of standard neuropsychological measures was also administered. No significant differences were observed between the two groups with respect to performance on any of the neuropsychological measures. However, with respect to the Cognometer battery, individuals with the epsilon4 allele were significantly slower in performing all the cognitive tasks, with the exception of the visuo-spatial task. With respect to performance, the two genotype groups did not differ significantly except on immediate memory, with the epsilon4 group exhibiting increased errors. Overall, the epsilon4 group was significantly slower in performing all of the Cognometer memory tasks. These findings provide continued support for the negative impact of the epsilon4 allele on cognition and further suggest that speed-of-processing during memory tasks may have the potential to detect subtle cognitive deficits.
    Journal of Psychiatric Research 03/2008; 42(3):199-204. DOI:10.1016/j.jpsychires.2006.12.001 · 4.09 Impact Factor
  • Source
    • "All of these inherited mutations directly or indirectly affect both the processing and accumulation of A␤. Familial Alzheimer disease (FAD) is associated with point mutations in amyloid-␤ protein precursor (A␤PP) in regions that are involved in the proteolytic processing of the peptide (Goate et al., 1991; Lendon et al., 1997). It is thought that these mutations accelerate the onset of AD into the fourth decade by increasing the ratio of A␤ 1– 42 /A␤ 1– 40 , thereby increasing the relative amount of the more fibrillogenic form (Suzuki et al., 1994). "
    [Show abstract] [Hide abstract]
    ABSTRACT: For nearly 20 years, the primary focus for researchers studying Alzheimer disease has been centered on amyloid-beta, such that the amyloid cascade hypothesis has become the "null hypothesis." Indeed, amyloid-beta is, by the current definition of the disease, an obligate player in pathophysiology, is toxic to neurons in vitro, and, perhaps most compelling, is increased by all of the human genetic influences on the disease. Therefore, targeting amyloid-beta is the focus of considerable basic and therapeutic interest. However, an increasingly vocal group of investigators are arriving at an "alternate hypothesis" stating that amyloid-beta, while certainly involved in the disease, is not an initiating event but rather is secondary to other pathogenic events. Furthermore and perhaps most contrary to current thinking, the alternate hypothesis proposes that the role of amyloid-beta is not as a harbinger of death but rather a protective response to neuronal insult. To determine which hypothesis relates best to Alzheimer disease requires a broader view of disease pathogenesis and is discussed herein.
    Journal of Pharmacology and Experimental Therapeutics 07/2007; 321(3):823-9. DOI:10.1124/jpet.106.114009 · 3.86 Impact Factor
Show more